Shareholder Alert: Ademi LLP Investigates Whether AgeX Therapeutics, Inc. Has Obtained a Fair Price in Its Transaction With Serina
Shareholder Alert: Ademi LLP Investigates Whether AgeX Therapeutics, Inc. Has Obtained a Fair Price in Its Transaction With Serina
MILWAUKEE, Aug. 30, 2023 /PRNewswire/ -- Ademi LLP is investigating AgeX (NYSE American: AGE) for possible breaches of fiduciary duty and other violations of law in its transaction with Serina.
密尔沃， 2023年8月30日 /PRNewswire/ — Ademi LLP正在调查AgeX（美国纽约证券交易所代码：AGE）在与Serina的交易中是否可能违反信托义务和其他违法行为。
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
点击此处了解如何加入或致电 Guri Ademi 免费电话 866-264-3995。您无需承担任何费用或义务。
Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. AgeX insiders will receive substantial benefits as part of change of control arrangements. In addition, AgeX will issue to each AgeX stockholder three warrants for each five shares of AgeX common stock held by such stockholder (each a "Post-Merger Warrant"). Each Post-Merger Warrant will be exercisable for one unit at a price equal to $13.20 and will expire on July 31, 2025. Each unit will consist of (i) one share of common stock of AgeX and (ii) one warrant (each such warrant, an "Incentive Warrant") that will be exercisable to purchase one share of common stock of AgeX at a price equal to $18.00 and that will expire in four years.
合并完成后，预计合并前的AgeX股东将拥有新合并公司约25％的股份，而合并前的Serina股东预计将拥有新合并公司约75％的股份。作为控制权变更安排的一部分，AgeX内部人士将获得可观的收益。此外，AgeX将向每位AgeX股东每持有五股AgeX普通股发行三份认股权证（每股都是 “合并后认股权证”）。每份合并后认股权证可按一个单位行使，价格等于 13.20 美元 并将于 2025年7月31日。每个单位将包括 (i) 一股AgeX普通股和 (ii) 一份认股权证（每份此类认股权证，“激励权证”），该认股权证可行使以等于以下价格购买一股AgeX普通股 18.00 美元 这将在四年后到期。
We are investigating the conduct of AgeX's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我们正在调查AgeX董事会的行为，以及他们是否履行了对所有股东的信托义务。
If you own AgeX common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您拥有AgeX普通股并希望获得更多信息，请联系 Guri Ademi 要么在 [电子邮件保护] 或者免费电话：866-264-3995，或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我们专门处理涉及收购、合并和全国各地个人股东权利的股东诉讼。欲了解更多信息，请随时致电我们。律师广告。先前的结果并不能保证类似的结果。
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
联系人
Ademi LLP
Guri Ademi
免费电话：(866) 264-3995
传真：(414) 482-8001
SOURCE Ademi LLP
来源 Ademi LLP
译文内容由第三方软件翻译。